search
Back to results

An Individualized Physical Activity Program in Patients Over 65 Years With Hematologic Malignancies (OCAPI)

Primary Purpose

Aged, Aged, 80 and Over, Leukemia, Myeloid, Acute

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Individualized physical activity program
Sponsored by
Centre Leon Berard
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Aged

Eligibility Criteria

65 Years - undefined (Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age 65 and over,
  • With histologically confirmed non-Hodgkin's lymphoma (NHL) or acute myeloid leukemia (AML),
  • Requiring a first line of chemotherapy treatment or Azacitidine - Vénétoclax combination,
  • Followed-up in one of the investigating centers,
  • Residing in one of the following departments: Ain, Ardèche, Drôme, Isère, Loire, Rhône, Savoie, Haute-Savoie,
  • Having a ECOG < 3,
  • With a life expectancy > 6 months,
  • Whose ability to engage in physical activity has been certified by a medical certificate issued by the investigator physician,
  • Available and willing to participate in the study for the duration of the intervention and follow-up,
  • Able to understand, read and write French,
  • Affiliated with a social security scheme,
  • Having dated and signed an informed consent.

Exclusion Criteria:

  • Personal history or co-existence of another primary cancer (except of in situ cancer regardless of the site and/or basal cell skin cancer and/or non-mammary cancer in complete remission for more than 5 years),
  • Treated by immunotherapy alone,
  • Participating in concurrent physical activity studies,
  • Deprived of their liberty by court or administrative decision.

Sites / Locations

  • Centre Léon Bérard

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Individualized physical activity program

Arm Description

Outcomes

Primary Outcome Measures

Compliance rate of the physical activity sessions
Ratio of the number of supervised and unsupervised sessions performed by patients / number of scheduled sessions
Compliance rate of the phone calls
Ratio of the number of phone calls performed / number of scheduled calls
Compliance rate of the activity tracker
Ratio of the number of days wearing the activity tracker / number of days of the program

Secondary Outcome Measures

Acceptability of the intervention
Ratio of number of patients included / number of eligible patients
Safety of the intervention
Number, type and timing of program-related adverse events
Adherence of the intervention
Ratio of the number of patients still in the program / number of patients included in the study
Impact of the program on autonomy for activities of daily living
Activities of Daily Living questionnaire (ADL) - scale from 0 to 6, 0=autonomy; 6 = no autonomy
Impact of the program on autonomy for instrumental activities of daily living
Instrumental activities of Daily Living questionnaire (IADL) - scale from 0 to 4, 0=autonomy; 4 = no autonomy
Impact of the program on upper body strength
30-s Arm Curl Test
Impact of the program on lower body strength
30-s Chair Stand Test
Impact of the program on upper body flexibility
Back Scratch Test
Impact of the program on lower body flexibility
Chair Sit and Reach Test
Impact of the program on agility
Timed Up and Go Test
Impact of the program on walking endurance
6-min Walk Test
Impact of the program on walking speed
10-m Walk Test
Impact of the program on balance
Open-eyes Unipodal Test
Impact of the program on grip strength
Hand Grip Dynamometer Test
Impact of the program on anthropometrics
BMI (weight and height will be combined to report BMI in kg/m^2)
Impact of the program on nutrition
Mini Nutritional Assessment (MNA) - scale from 0 to 30 points; score<17=bad nutritional status ; 17 and 23.5=risk of malnutrition ; >24: adaptednutritional status
Impact of the program on cognition
Montreal Cognitive Assessment (MoCA) ; scale from 0 to 30; normal if score >16
Impact of the program on depression
Geriatric Depression Scale-15 (GDS-15) ; scale from 0 to 15 ; 0 to 5=normal ; 6 and 9 = high probability of depression ; > 9 = almost systematic depression
Impact of the program on self-efficacy
Self-efficacy for exercise scale - This scale has a range of total scores from 0-90. A higher score indicates higher self-efficacy for exercise.
Impact of the program on comorbidities
Cumulativ Illness Rating Scale - Geriatric (CIRS-G) ; 14 items ; for each one, score from 0 to 4 : 0=no problem and 4=serious issue
Impact of the program on health-related quality of life
European Organization for Research and Treatment of Cancer core quality of life questionnaire (EORTC QLQ-C30) - scale from 0 to 100
Impact of the program on fatigue
Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) ; score from 0 to 65 ; the higher the score is, the less the patient has fatigue
Impact of the program on the level of physical activity
Godin-Shephard Leisure-Time Physical Activity Questionnaire (GSLTPAQ) ; Godin scale score: < 14 units: insufficiently active/sedentary ; 14-23: moderately active ; 24 or more : active
Impact of the program on exercise barriers
Barriers to Being Active Quiz
Impact of the program on social vulnerability
Évaluation de la précarité et des inégalités de santé pour les CES (EPICES questionnaire) - scale from 0 to 100, 0= no social vulnerability, 100=max vulnerability, threshold=30
Impact of the program on falls
Number of falls

Full Information

First Posted
August 6, 2019
Last Updated
August 29, 2023
Sponsor
Centre Leon Berard
search

1. Study Identification

Unique Protocol Identification Number
NCT04052126
Brief Title
An Individualized Physical Activity Program in Patients Over 65 Years With Hematologic Malignancies
Acronym
OCAPI
Official Title
An Interventional Prospective Study to Test the Feasibility of an Individualized Physical Activity Program in Patients Over 65 Years of Age With Hematologic Malignancies: the OCAPI Project.
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Completed
Study Start Date
November 28, 2019 (Actual)
Primary Completion Date
November 23, 2022 (Actual)
Study Completion Date
May 30, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Leon Berard

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Older people with cancer differ from younger patients due to the combined effects of aging, comorbidities and cancer treatments on their health. In acute myeloid leukemia (AML) and non-hodgkin lymphoma (NHL), chemotherapy, which is the main treatment, is associated with significant toxicity that negatively affects patients' physical capacities and quality of life, already declining with age and comorbidities. It therefore seems essential to develop and evaluate interventions that can prevent physical and psychosocial decline and its consequences in these populations. However, no studies have evaluated a physical activity (PA) program among these populations, although the absence of risk of implementing PA during intense therapeutic procedures has been confirmed. OCAPI is an interdisciplinary, prospective, interventional, feasibility study. It is intended to include 20 AML and 20 NHL patients 65 years of age or older at the time of initiation of the first chemotherapy line, with an ECOG <3, with no contraindications to PA and no history or coexistence of other primary cancer. Expected results are to demonstrate that a program offering supervised sessions in a sterile room or at home and remote support can enable patients with AML or NHL to perform their daily PA in autonomy. All these results will generate preliminary data before implementing a larger national study.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Aged, Aged, 80 and Over, Leukemia, Myeloid, Acute, Lymphoma, Non-Hodgkin, Exercise, Quality of Life, Fatigue

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
43 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Individualized physical activity program
Arm Type
Experimental
Intervention Type
Other
Intervention Name(s)
Individualized physical activity program
Intervention Description
Participants who agreed to participate in the study will participate in an individualized 6-month physical activity (PA) program, consisting of 3 periods: initiation (1st month), transition (2nd-3rd months) and autonomy (4th-6th months). It is based on 4 PA modalities: The supervised PA session in a sterile room or at home once a week during the initiation and transition phases (20-45 min, low-to-moderate intensity, walking, muscle strengthening, balance and flexibility exercises). The unsupervised PA session in a sterile room or at home once a week during the transition phase and twice a week during the autonomy phase (same as supervised session). Follow-up by telephone once a month during the autonomy phase (30 min, support to PA). Continuously wearing an activity tracker throughout the entire program (promotion of walking). Activities are planned over a period of 6 months to achieve an intervention that meets the key principles of progression, specificity and empowerment.
Primary Outcome Measure Information:
Title
Compliance rate of the physical activity sessions
Description
Ratio of the number of supervised and unsupervised sessions performed by patients / number of scheduled sessions
Time Frame
6 months
Title
Compliance rate of the phone calls
Description
Ratio of the number of phone calls performed / number of scheduled calls
Time Frame
6 months
Title
Compliance rate of the activity tracker
Description
Ratio of the number of days wearing the activity tracker / number of days of the program
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Acceptability of the intervention
Description
Ratio of number of patients included / number of eligible patients
Time Frame
At inclusion
Title
Safety of the intervention
Description
Number, type and timing of program-related adverse events
Time Frame
6 months
Title
Adherence of the intervention
Description
Ratio of the number of patients still in the program / number of patients included in the study
Time Frame
3 months and 6 months
Title
Impact of the program on autonomy for activities of daily living
Description
Activities of Daily Living questionnaire (ADL) - scale from 0 to 6, 0=autonomy; 6 = no autonomy
Time Frame
At inclusion, 3 months and 6 months
Title
Impact of the program on autonomy for instrumental activities of daily living
Description
Instrumental activities of Daily Living questionnaire (IADL) - scale from 0 to 4, 0=autonomy; 4 = no autonomy
Time Frame
At inclusion, 3 months and 6 months
Title
Impact of the program on upper body strength
Description
30-s Arm Curl Test
Time Frame
At inclusion, 3 months and 6 months
Title
Impact of the program on lower body strength
Description
30-s Chair Stand Test
Time Frame
At inclusion, 3 months and 6 months
Title
Impact of the program on upper body flexibility
Description
Back Scratch Test
Time Frame
At inclusion, 3 months and 6 months
Title
Impact of the program on lower body flexibility
Description
Chair Sit and Reach Test
Time Frame
At inclusion, 3 months and 6 months
Title
Impact of the program on agility
Description
Timed Up and Go Test
Time Frame
At inclusion, 3 months and 6 months
Title
Impact of the program on walking endurance
Description
6-min Walk Test
Time Frame
At inclusion, 3 months and 6 months
Title
Impact of the program on walking speed
Description
10-m Walk Test
Time Frame
At inclusion, 3 months and 6 months
Title
Impact of the program on balance
Description
Open-eyes Unipodal Test
Time Frame
At inclusion, 3 months and 6 months
Title
Impact of the program on grip strength
Description
Hand Grip Dynamometer Test
Time Frame
At inclusion, 3 months and 6 months
Title
Impact of the program on anthropometrics
Description
BMI (weight and height will be combined to report BMI in kg/m^2)
Time Frame
At inclusion, 3 months and 6 months
Title
Impact of the program on nutrition
Description
Mini Nutritional Assessment (MNA) - scale from 0 to 30 points; score<17=bad nutritional status ; 17 and 23.5=risk of malnutrition ; >24: adaptednutritional status
Time Frame
At inclusion, 3 months and 6 months
Title
Impact of the program on cognition
Description
Montreal Cognitive Assessment (MoCA) ; scale from 0 to 30; normal if score >16
Time Frame
At inclusion, 3 months and 6 months
Title
Impact of the program on depression
Description
Geriatric Depression Scale-15 (GDS-15) ; scale from 0 to 15 ; 0 to 5=normal ; 6 and 9 = high probability of depression ; > 9 = almost systematic depression
Time Frame
At inclusion, 3 months and 6 months
Title
Impact of the program on self-efficacy
Description
Self-efficacy for exercise scale - This scale has a range of total scores from 0-90. A higher score indicates higher self-efficacy for exercise.
Time Frame
At inclusion, 3 months and 6 months
Title
Impact of the program on comorbidities
Description
Cumulativ Illness Rating Scale - Geriatric (CIRS-G) ; 14 items ; for each one, score from 0 to 4 : 0=no problem and 4=serious issue
Time Frame
At inclusion, 3 months and 6 months
Title
Impact of the program on health-related quality of life
Description
European Organization for Research and Treatment of Cancer core quality of life questionnaire (EORTC QLQ-C30) - scale from 0 to 100
Time Frame
At inclusion, 3 months, 6 months and 1 year
Title
Impact of the program on fatigue
Description
Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) ; score from 0 to 65 ; the higher the score is, the less the patient has fatigue
Time Frame
At inclusion, 3 months, 6 months and 1 year
Title
Impact of the program on the level of physical activity
Description
Godin-Shephard Leisure-Time Physical Activity Questionnaire (GSLTPAQ) ; Godin scale score: < 14 units: insufficiently active/sedentary ; 14-23: moderately active ; 24 or more : active
Time Frame
At inclusion, 3 months, 6 months and 1 year
Title
Impact of the program on exercise barriers
Description
Barriers to Being Active Quiz
Time Frame
At inclusion, 3 months, 6 months and 1 year
Title
Impact of the program on social vulnerability
Description
Évaluation de la précarité et des inégalités de santé pour les CES (EPICES questionnaire) - scale from 0 to 100, 0= no social vulnerability, 100=max vulnerability, threshold=30
Time Frame
At inclusion and 1 year
Title
Impact of the program on falls
Description
Number of falls
Time Frame
At inclusion and 1 year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 65 and over, With histologically confirmed non-Hodgkin's lymphoma (NHL) or acute myeloid leukemia (AML), Requiring a first line of chemotherapy treatment or Azacitidine - Vénétoclax combination, Followed-up in one of the investigating centers, Residing in one of the following departments: Ain, Ardèche, Drôme, Isère, Loire, Rhône, Savoie, Haute-Savoie, Having a ECOG < 3, With a life expectancy > 6 months, Whose ability to engage in physical activity has been certified by a medical certificate issued by the investigator physician, Available and willing to participate in the study for the duration of the intervention and follow-up, Able to understand, read and write French, Affiliated with a social security scheme, Having dated and signed an informed consent. Exclusion Criteria: Personal history or co-existence of another primary cancer (except of in situ cancer regardless of the site and/or basal cell skin cancer and/or non-mammary cancer in complete remission for more than 5 years), Treated by immunotherapy alone, Participating in concurrent physical activity studies, Deprived of their liberty by court or administrative decision.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Emmanuelle NICOLAS-VIRELIZIER
Organizational Affiliation
Centre Leon Berard
Official's Role
Principal Investigator
Facility Information:
Facility Name
Centre Léon Bérard
City
Lyon
ZIP/Postal Code
69008
Country
France

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
34083339
Citation
Fournier B, Nicolas-Virelizier E, Russo C, Perol O, Millet GY, Maire A, Delrieu L, Michallet AS, Assaad S, Belhabri A, Gilis L, Guillermin Y, Lebras L, Rey P, Santana C, Pretet-Flamand E, Terret C, Michallet M, Fervers B. Individualised physical activity programme in patients over 65 years with haematological malignancies (OCAPI): protocol for a single-arm feasibility trial. BMJ Open. 2021 Jun 3;11(6):e046409. doi: 10.1136/bmjopen-2020-046409.
Results Reference
derived

Learn more about this trial

An Individualized Physical Activity Program in Patients Over 65 Years With Hematologic Malignancies

We'll reach out to this number within 24 hrs